KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares Outstanding
Ratios

Biogen (BIIB) Cost of Revenue (2016 - 2026)

Biogen has reported Cost of Revenue over the past 18 years, most recently at $661.0 million for Q1 2026.

  • For Q1 2026, Cost of Revenue rose 5.04% year-over-year to $661.0 million; the TTM value through Mar 2026 reached $2.4 billion, up 1.6%, while the annual FY2025 figure was $2.4 billion, 4.06% up from the prior year.
  • Cost of Revenue for Q1 2026 was $661.0 million at Biogen, up from $495.5 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $674.4 million in Q3 2025 and troughed at $164.0 million in Q4 2022.
  • A 5-year average of $520.4 million and a median of $583.5 million in 2024 define the central range for Cost of Revenue.
  • Biggest five-year swings in Cost of Revenue: crashed 42.48% in 2022 and later surged 255.79% in 2024.
  • Year by year, Cost of Revenue stood at $164.0 million in 2022, then changed by 0.0% to $164.0 million in 2023, then surged by 255.79% to $583.5 million in 2024, then decreased by 15.08% to $495.5 million in 2025, then surged by 33.4% to $661.0 million in 2026.
  • Business Quant data shows Cost of Revenue for BIIB at $661.0 million in Q1 2026, $495.5 million in Q4 2025, and $674.4 million in Q3 2025.